CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Swanson James D. EVP, CIO | Option exercise | +447 | 15,018.59 | ||
| 2025-02-13 | Swanson James D. EVP, CIO | Option exercise · Restricted Share Units | −447 | 447 | ||
| 2025-02-13 | Mulholland Kristen EVP, Chief HR Officer | Option exercise | +411 | 12,100 | ||
| 2025-02-13 | Mulholland Kristen EVP, Chief HR Officer | Option exercise · Restricted Share Units | −411 | 410 | ||
| 2025-02-13 | Forminard Elizabeth Executive VP, General Counsel | Option exercise | +651 | 8,991 | ||
| 2025-02-13 | Forminard Elizabeth Executive VP, General Counsel | Option exercise · Restricted Share Units | −651 | 651 | ||
| 2025-02-13 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +3,470 | 392,498 | ||
| 2025-02-13 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Restricted Share Units | −3,470 | 3,469 | ||
| 2025-02-13 | Decker Robert J VP Corporate Controller | Option exercise | +312 | 19,285 | ||
| 2025-02-13 | Decker Robert J VP Corporate Controller | Option exercise · Restricted Share Units | −312 | 312 | ||
| 2025-02-13 | Broadhurst Vanessa EVP, Global Corp Affairs | Option exercise | +408 | 20,242 | ||
| 2025-02-13 | Broadhurst Vanessa EVP, Global Corp Affairs | Option exercise · Restricted Share Units | −408 | 408 | ||
| 2025-02-10 | Decker Robert J VP Corporate Controller | Grant or award · Performance Share Units | +1,351 | 1,351 | ||
| 2025-02-10 | Forminard Elizabeth Executive VP, General Counsel | Grant or award · Performance Share Units | +1,352 | 1,352 | ||
| 2025-02-10 | Wolk Joseph J Exec VP, CFO | Grant or award · Performance Share Units | +15,316 | 15,316 | ||
| 2025-02-10 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Grant or award · Performance Share Units | +5,837 | 5,837 | ||
| 2025-02-10 | Mulholland Kristen EVP, Chief HR Officer | Grant or award · Performance Share Units | +1,601 | 1,601 | ||
| 2025-02-10 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Grant or award · Performance Share Units | +15,465 | 15,465 | ||
| 2025-02-10 | Schmid Timothy EVP, WW Chair, MedTech | Grant or award · Performance Share Units | +2,806 | 2,806 | ||
| 2025-02-10 | Swanson James D. EVP, CIO | Grant or award · Performance Share Units | +3,118 | 3,118 |
Page 23 of 33 · 658 trades